Kalaris Therapeutics (KLRS) EBIT (2019 - 2026)
Kalaris Therapeutics (KLRS) posted EBIT of -$12.39 million for Q2 2026, compared with -$12.26 million a year earlier.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) EBIT (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT at Kalaris Therapeutics was -$47.76 million; for FY2025, it came in at -$46.15 million.
- In prior years, Kalaris Therapeutics' EBIT was -$51.73 million in FY2024, -$199.9 million in FY2023, -$171.2 million in FY2022 and -$169.82 million in FY2021.
- Quarterly EBIT has run from a low of -$62.41 million in Q4 2023 to a high of -$2.56 million in Q1 2024 over five years.
- According to Business Quant data, EBIT for the three prior quarters was -$11.83 million (Q1 2026), -$10.8 million (Q4 2025) and -$12.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Kalaris Therapeutics | 47.48 Mn | -46.02 Mn | - | -12.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.39 Mn |
| Mar 31, 2026 | -11.83 Mn |
| Dec 31, 2025 | -10.80 Mn |
| Sep 30, 2025 | -12.74 Mn |
| Jun 30, 2025 | -12.26 Mn |
| Mar 31, 2025 | -10.35 Mn |
| Dec 31, 2024 | -7.13 Mn |
| Sep 30, 2024 | -37.85 Mn |
| Jun 30, 2024 | -4.19 Mn |
| Mar 31, 2024 | -2.56 Mn |
| Dec 31, 2023 | -62.41 Mn |
| Sep 30, 2023 | -46.96 Mn |
| Jun 30, 2023 | -47.30 Mn |
| Mar 31, 2023 | -43.23 Mn |
| Dec 31, 2022 | -40.43 Mn |
| Sep 30, 2022 | -42.95 Mn |
| Jun 30, 2022 | -44.62 Mn |
| Mar 31, 2022 | -43.19 Mn |
| Dec 31, 2021 | -55.80 Mn |
| Sep 30, 2021 | -45.50 Mn |
API Access
Kalaris Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();